首页> 美国卫生研究院文献>Chronic Diseases and Translational Medicine >The era of clinical application of gene diagnosis in cardiovascular diseases is coming
【2h】

The era of clinical application of gene diagnosis in cardiovascular diseases is coming

机译:基因诊断在心血管疾病中的临床应用时代正在到来

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gene diagnosis refers to the use of genetic testing in the diagnosis of inheritable conditions, which has gradually been applied in clinical practice with the completion of the gene sequencing efforts of the Human Genome Project and the advancement of gene detection technology. In the specialty field of cardiology, monogenic cardiovascular diseases are defined as monogenic inherited diseases with cardiovascular damage as the only phenotype, or accompanied by cardiovascular damage. Although the incidence of such diseases is relatively low, in the country of China with its vast population of 1.33 billion, the sheer volume of patients with monogenic cardiovascular diseases is alarming. With early onset, severe symptoms, and poor prognosis, delays in diagnosis and treatment of monogenic cardiovascular diseases often have serious consequences. Gene testing is perfectly suited for early diagnosis of monogenic cardiovascular diseases, especially for “pre-symptomatic” diagnosis. In this article, we generally review the characteristics of common monogenic cardiovascular diseases, summarize the progress of the standardized application of gene testing technology in clinical practice, describe the applicable population and condition of genetic testing for different monogenic cardiovascular diseases, analyze the practicality of genetic diagnosis of these inheritable conditions, and provide guidance on identifying suitable candidates for gene diagnosis. In conclusion, gene diagnosis provides new insights into the way physicians diagnose diseases, and is well-positioned to guide clinical decision making and treatment, especially in cardiology.
机译:基因诊断是指将基因检测用于遗传性疾病的诊断,随着人类基因组计划的基因测序工作的完成和基因检测技术的发展,这种方法已逐渐应用于临床实践。在心脏病学的专业领域,单基因性心血管疾病定义为单基因遗传性疾病,其中以心血管损害为唯一表型,或伴有心血管损害。尽管此类疾病的发病率相对较低,但在中国这个拥有13.3亿人口的国家中,单基因心血管疾病患者的数量之多令人震惊。由于发病早,症状严重,预后差,单基因心血管疾病的诊断和治疗延误通常会造成严重后果。基因检测非常适合单基因心血管疾病的早期诊断,尤其是“症状前”诊断。在本文中,我们概述了常见的单基因心血管疾病的特征,总结了基因检测技术在临床实践中标准化应用的进展,描述了针对各种单基因心血管疾病的基因检测的适用人群和条件,分析了遗传学的实用性这些遗传病的诊断,并为确定合适的基因诊断候选者提供指导。总之,基因诊断为医生诊断疾病提供了新的见解,并且可以很好地指导临床决策和治疗,尤其是在心脏病方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号